Neurocrine Bioscience buy The Goldman Sachs Group, Inc.
Start price
10.07.25
/
50%
€114.40
Target price
10.07.26
€154.99
Performance (%)
-1.05%
Price
17.04.26
€113.20
Summary
This prediction is currently active. With a performance of -1.05%, the BUY prediction by The_Goldman_Sachs_Gr is trending in the wrong direction. This prediction currently runs until 10.07.26. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Neurocrine Bioscience | 2.956% | 2.956% |
| iShares Core DAX® | 3,59 % | 6,43 % |
| iShares Nasdaq 100 | 5,81 % | 6,38 % |
| iShares Nikkei 225® | 4,08 % | 9,31 % |
| iShares S&P 500 | 4,14 % | 4,94 % |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $182.00 price target on the stock.
Ratings data for NBIX provided by MarketBeat
Stopped prediction by The_Goldman_Sachs_Gr for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€128.55
25.01.24
25.01.24
€140.87
25.01.25
25.01.25
9.80%
26.01.25
26.01.25
